Researchers have developed a novel method for treating liver failure by injecting engineered "mini livers." These grafts, composed of hepatocytes encapsulated in hydrogel microspheres, can be administered via syringe and integrate with the host's circulatory system. The technology aims to provide a temporary solution for patients awaiting transplants or those unable to undergo surgery, with the potential to function for several months. AI
RANK_REASON Novel biomedical research publication detailing a new therapeutic approach. [lever_c_demoted from research: ic=1 ai=0.1]
Read on MIT Technology Review →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
